Novel transcript, antisense to CRABP2 (ENSG00000285570)

This transcript is a non-coding RNA that is antisense to the protein-coding gene CRABP2 on chromosome 1. Its biological function and clinical significance, if any, are unknown. There is no evidence in the literature or major genomic databases supporting its role as a therapeutic target, disease marker, or as having a defined biological function[2]. The target is a long non-coding RNA (or other transcript) that runs antisense to the well-characterized "Cellular retinoic acid binding protein 2" (CRABP2) gene. There is no evidence this transcript codes for a protein or serves as a functional receptor, enzyme, or drug target[2]. No molecular function, associated diseases, or therapeutic relevance are found for ENSG00000285570 in Ensembl or in aggregated gene/protein databases[2]. The naming ("novel transcript") and absence of additional aliases or functional annotation suggest this is a computationally predicted, uncharacterized transcript, and not an established target. In summary, ENSG00000285570 is not an established therapeutic target, does not have a canonical protein name, and should not currently be considered a relevant molecule for drug discovery or clinical biomarker research[2].